Detection of Human Beta Cell Death in Type 1 Diabetes Mellitus (T1DM) by Methylation Specific Polymerase Chain Reaction (PCR)

Completed

Conditions studied: Type 1 Diabetes Mellitus

In brief

To investigate the use of methylation-specific PCR (MSP) assays to detect human beta cell-specific gene methylation patterns in serial blood samples drawn from newly diagnosed Type 1 diabetics.

Key facts

Study ID

NCT01176253

Run by

City of Hope Medical Center

People needed

6

Starts

2009-07-01

Expected to finish

2015-04-01

Last updated by the study team

2015-05-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy volunteers:
• Age > 18 years of age,
• Otherwise healthy individuals with no cancer and not pregnant.
• Type 1DM:
• Newly diagnosed type I diabetes,
• Age > 18 years of age,
• Otherwise healthy individuals with no severe complications, no cancer, not pregnant,
• Willing and able to comply with the scheduled visits to the clinic for blood sampling,
• Remain under the continuing care of an Endocrinologist.

Where it is running

• City of Hope National Medical Center-Department of Diabetes, Endocrinology, & Metabolism — Duarte, California, United States
• Loma Linda Medical Center — Loma Linda, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.